Vall d’Hebron Institute of Oncology
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Vall d’Hebron Institute of Oncology
Sep 14, 2024, 17:16 |
Societies
Highlights of the CSO symposium from ESMO24
The Common Sense Oncology symposium, hosted by Drs. Bishal Gyawali, Winnette van der Graaf, Dario…
Sep 1, 2024, 15:26 |
Insight
Guillermo Villacampa: Meta-analysis evaluating immunotherapy in early breast cancer
Recently, an article by Guillermo Villacampa et al. was published in JAMA Oncology. "Neoadjuvant Immune…
Sep 1, 2024, 09:51 |
Blog
Sara Gutiérrez-Enríquez: Our Work on hereditary breast/ovarian cancer and Radiogenomics
Sara Gutiérrez-Enríquez, Molecular geneticist at Vall d'Hebron Institute of Oncology, shared a post on X:…
Jul 31, 2024, 09:16 |
Blog
Emerging Leaders in Biomedicine Symposium at VHIO
Vall d’Hebron Institute of Oncology (VHIO) shared a post on X: "Join us for the…
Jul 30, 2024, 02:42 |
Insight
Why does Lionel Messi donate so much to charity?
Can Golden-Hearted Messi Use His Golden Foot to Fight Cancer? When we think of Lionel…
Jul 16, 2024, 11:02 |
Blog
New VHIO- Caixa Research Scientific Seminar
Vall d'Hebron Institute of Oncology shared on LinkedIn: "New VHIO- Caixa Research Scientific Seminar‼️ Breast cancer…
Jul 10, 2024, 01:24 |
Blog
Joaquin Mateo: Dual DNA/mRNA profiling in prostate cancer liquid biopsies
Joaquin Mateo, Physician-Scientist at Vall d’Hebron Institute of Oncology (VHIO), shared on X: "New paper from…
Jul 2, 2024, 14:28 |
Blog
Mario Balsa: How to modulate the microbiome to improve results
Mario Balsa, Medical Oncology resident at ICO, shared on X: "Super interesting session about how to…
Jul 1, 2024, 15:23 |
Insight
Paolo Tarantino: Final analysis of the ATEMPT phase 2 trial
Paolo Tarantino shared a post on X: “Can ADCs help prevent recurrence from breast cancer…
Jun 29, 2024, 13:12 |
Societies
Poster on early-onset CCA won Best Poster at ESMOGI24
Natalia Tissera, PhD Student at Vall d'Hebron Institute of Oncology (VHIO), shared on X: "Thrilled…
Jun 27, 2024, 14:31 |
Societies
Keep up with ESMOGI24 with Teresa Macarulla
ESMO GI 2024 is taking place as an onsite event in Munich, Germany, from 26 to 29…
May 17, 2024, 16:02 |
Blog
Marta Perachino: Check out our systematic review and metanalysis of ADCs vs TPC for mBC
Marta Perachino, Research fellow at Vall d’Hebron Institute of Oncology, shared a post on X: "For…
Dec 7, 2023, 04:20 |
Blog
Josep Tabernero: The 1st VHIO- Fundacion BBVA International Symposium on 'Cell-based Therapies in Oncology' a success
Josep Tabernero, Head of the Medical Oncology Department at the Vall d'Hebron Barcelona Hospital Campus,…
Oct 14, 2023, 18:26 |
Blog
VIGex: a VHIO-developed predictive, pan-cancer platform to help guide patient selection for personalized immunotherapy. - Vall d'Hebron Institute of Oncology
Quoting Vall d'Hebron Institute of Oncology on LinkedIn: "VIGex: a VHIO-developed predictive, pan-cancer platform to…
Sep 19, 2023, 19:42 |
Insight
Josep Tabernero: This research was born out of a patient's concern.
Josep Tabernero, Head of the Medical Oncology Department at the Vall d’Hebron Barcelona Hospital campus,…
All:
15
Posts:
1 - 100
Making Personal Experience a Political Priority: Insights from EU Commissioner Stella Kyriakides
Zolbetuximab is now approved by the US FDA
Highlights from NFCR’s GSAC24
SIOP Honoured Hansjörg Riehm with the 2024 Lifetime Achievement Award
Margaret Foti has received the 2024 Beacon Award for Women Leaders in Oncology
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube